New therapeutic strategies for the treatment of patent ductus arteriosus in preterm infants
- 12 October 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 24 (sup3), 5-6
- https://doi.org/10.3109/14767058.2011.607955
Abstract
A high percentage of preterm infants fails to respond to a single course of indomethacin or ibuprofen. Thus, it has been suggested that the actual dose regimens of these drugs could be inadequate because of large interindividual pharmacokinetics variations in premature infants. We tested the hypothesis that a high-dose regimen of ibuprofen was more effective than the current regimen in closing PDA. We demonstrated that a single course of ibuprofen at 20-10-10 mg/kg/day is more effective than a 10-5-5 mg/kg/day course in closing PDA without significant adverse effects. Many other questions regarding the pharmacological treatment of PDA are still debated.Keywords
This publication has 10 references indexed in Scilit:
- Relationship between Circulating Platelet Counts and Ductus Arteriosus Patency after Indomethacin TreatmentThe Journal of Pediatrics, 2011
- Efficacy and Safety of Oral Versus Intravenous Ibuprofen in Very Low Birth Weight Preterm Infants with Patent Ductus ArteriosusThe Journal of Pediatrics, 2011
- Inadvertent Relaxation of the Ductus Arteriosus by Pharmacologic Agents that are Commonly Used in the Neonatal PeriodSeminars in Perinatology, 2010
- Insights into the Pathogenesis and Genetic Background of Patency of the Ductus ArteriosusNeonatology, 2009
- Increased Indomethacin Dosing for Persistent Patent Ductus Arteriosus in Preterm Infants: A Multicenter, Randomized, Controlled TrialThe Journal of Pediatrics, 2008
- The fate of ductus arteriosus in infants at 23–27 weeks of gestation: from spontaneous closure to ibuprofen resistanceActa Paediatrica, 2008
- An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic studyBritish Journal of Clinical Pharmacology, 2008
- Effectiveness and Side Effects of an Escalating, Stepwise Approach to Indomethacin Treatment for Symptomatic Patent Ductus Arteriosus in Premature Infants Below 33 Weeks of GestationPEDIATRICS, 2005
- Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment methodJournal of Clinical Pharmacy & Therapeutics, 2005
- Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosusClinical Pharmacology & Therapeutics, 2001